The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders. (2021)
Attributed to:
Unravelling biological heterogeneity in neoplastic myeloproliferative stem cells
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.17766
PubMed Identifier: 34409596
Publication URI: http://europepmc.org/abstract/MED/34409596
Type: Journal Article/Review
Volume: 195
Parent Publication: British journal of haematology
Issue: 3
ISSN: 0007-1048